اخبار بازار

آخرین اخبار مالی و اقتصادی، تحولات بازار، گزارش‌ها و تحلیل‌های بازارهای مالی را در PipVero دنبال کنید.

منبع: Proactive Investors خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Genel rejects £202 million cash approach from DNO

Genel rejects £202 million cash approach from DNO

Genel Energy PLC (LSE:GENL, FRA:4VL, OTC:GEGYY) has rejected a £202 million cash approach from DNO, its Norwegian rival in the Kurdistan region of Iraq. DNO has taken the proposal public after being rebuffed, a move that raises pressure on the Genel board to open talks.

نمادهای مرتبط 1
GEGYY GEGYY
منبع: Proactive Investors
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Proactive Investors خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Oxford Biomedica cuts 2026 revenue guidance as clients delay orders

Oxford Biomedica cuts 2026 revenue guidance as clients delay orders

Oxford BioMedica PLC (LSE:OXB), the cell and gene therapy manufacturer, has cut its revenue guidance for 2026 after clients deferred orders and a US site took longer than expected to come online. The company now expects full-year revenues of £180 million to £200 million.

نمادهای مرتبط 1
OXB OXB
منبع: Proactive Investors
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Reuters خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Israel's Ratio Petroleum sweetens Pharos Energy offer, outbidding Serica

Israel's Ratio Petroleum sweetens Pharos Energy offer, outbidding Serica

Israel-based Ratio Petroleum Energy raised its takeover bid for Pharos Energy to about £146.4 ​million ($196.97 million) on Friday, outbidding rival oil ‌producer Serica Energy and winning back the board's recommendation.

نمادهای مرتبط 1
SOCLF SOCLF
منبع: Reuters
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: MarketBeat خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Ocugen Q2 Earnings Call Highlights

Ocugen Q2 Earnings Call Highlights

Ocugen NASDAQ: OCGN said its second quarter marked progress across its late-stage ophthalmology pipeline, including FDA clearance to begin a Phase III study of OCU410 in geographic atrophy and an RMAT designation for the program.

نمادهای مرتبط 1
OCGN OCGN
منبع: MarketBeat
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: MarketBeat خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
OmniAb Q2 Earnings Call Highlights

OmniAb Q2 Earnings Call Highlights

OmniAb NASDAQ: OABI reported higher second-quarter revenue and a narrower net loss as milestone payments from partner programs increased, while the company raised its full-year 2026 revenue and year-end cash outlook.

نمادهای مرتبط 1
OABI OABI
منبع: MarketBeat
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: MarketBeat خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Nova Q2 Earnings Call Highlights

Nova Q2 Earnings Call Highlights

Nova NASDAQ: NVMI reported record second-quarter revenue of $255 million, up 8% sequentially and 16% from a year earlier, as demand increased across its semiconductor process-control portfolio. The company said revenue reached the high end of its guidance range, while non-GAAP diluted earnings per share of $2.51 exceeded the high end of its outlook.

نمادهای مرتبط 1
NVMI NVMI
منبع: MarketBeat
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: MarketBeat خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Novavax Q2 Earnings Call Highlights

Novavax Q2 Earnings Call Highlights

Novavax NASDAQ: NVAX reported second-quarter 2026 revenue of $57 million and a net loss of $53 million, while highlighting progress in its Sanofi partnership, expanding use of its Matrix-M adjuvant platform and continued cost reductions.

نمادهای مرتبط 1
NVAX NVAX
منبع: MarketBeat
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: MarketBeat خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Natera Q2 Earnings Call Highlights

Natera Q2 Earnings Call Highlights

Natera NASDAQ: NTRA reported second-quarter 2026 revenue of approximately $753 million, up about 38% from a year earlier, as record testing volumes and higher average selling prices supported growth across its oncology, women's health and organ health businesses.

نمادهای مرتبط 1
NTRA NTRA
منبع: MarketBeat
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: MarketBeat خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Intellia Therapeutics Q2 Earnings Call Highlights

Intellia Therapeutics Q2 Earnings Call Highlights

Intellia Therapeutics NASDAQ: NTLA said it advanced its lead gene-editing programs during the second quarter, highlighting positive Phase III results for lonvo-z in hereditary angioedema and the resumption of enrollment in Phase III studies of nex-z for transthyretin amyloidosis.

نمادهای مرتبط 1
NTLA NTLA
منبع: MarketBeat
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: MarketBeat خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
NETGEAR Q2 Earnings Call Highlights

NETGEAR Q2 Earnings Call Highlights

NETGEAR NASDAQ: NTGR reported second-quarter 2026 revenue of $168.6 million, down 1.2% from a year earlier but up 6.1% sequentially, as growth in its enterprise segment offset continued pressure in consumer products. The company said revenue and non-GAAP operating margin exceeded the high end of its guidance range.

نمادهای مرتبط 1
NTGR NTGR
منبع: MarketBeat
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: MarketBeat خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
NetScout Systems Q1 Earnings Call Highlights

NetScout Systems Q1 Earnings Call Highlights

NetScout Systems NASDAQ: NTCT reported first-quarter fiscal 2027 revenue growth of 13%, citing demand for its service assurance offerings, government-related orders and contributions from its recently acquired cloud DDoS business. The company reaffirmed its full-year outlook, while cautioning that some government orders arrived earlier than anticipated and are expected to affect second-quarter comparisons.

نمادهای مرتبط 1
NTCT NTCT
منبع: MarketBeat
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: MarketBeat خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Insight Enterprises Q2 Earnings Call Highlights

Insight Enterprises Q2 Earnings Call Highlights

Insight Enterprises NASDAQ: NSIT reported second-quarter results that exceeded its expectations, with broad-based growth in hardware, cloud and services helping drive operating leverage. The company raised its full-year outlook for gross profit growth and adjusted diluted earnings per share while outlining a three-year “One Insight Plan” centered on AI infrastructure, AI services, operational efficiency and talent development.

نمادهای مرتبط 1
NSIT NSIT
منبع: MarketBeat
مشاهده منبع
Official Partner ITBFX Start Trading
0 0 0
ادامه مطلب
نظر